Breast Cancer Clinical Trial

Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

Summary

This study is being done to find out the number of surgical procedures required to achieve clear margins in women with newly diagnosed early stage breast carcinoma. The investigators are also looking at the number of additional biopsies performed before surgery, the mastectomy rate, detection of breast cancer on the opposite side (contralateral carcinoma), time form diagnosis to local therapy, and evaluation time to local recurrence.

View Full Description

Full Description

This is a prospective pragmatic trial randomizing women diagnosed with early stage breast cancer to MRI versus no breast MRI. Data analyzed will include medical record information abstracted from the clinical records. Date and modality of all imaging performed, malignancy(s) identified, abnormalities identified, image guided procedures performed, surgical procedures performed and pathology results.

The primary aim of this study is to assess if the use of pre-operative MRI can reduce the incidence of re-excisions required to achieve clear margins in women with newly diagnosed early stage breast carcinoma.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Must undergo definitive local therapy with either breast conserving therapy or mastectomy
Clinical Stage 0, I or II breast cancer based on examination and/or conventional imaging of mammogram with or without ultrasound. Tumors must be less than 5 cm in size and the patient clinically node negative
Able to undergo breast MRI

Exclusion Criteria:

Not pregnant or breastfeeding
No prior breast MRI for the newly diagnosed carcinoma at the outside hospital
No prior mantle radiation
No locally advanced breast cancer
No diffuse malignant appearing microcalcifications requiring mastectomy
No known collagen vascular disease
No previous ipsilateral radiation
No participants who undergo surgery at an outside institution
No prior history of breast carcinoma

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

9

Study ID:

NCT01568346

Recruitment Status:

Terminated

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Brigham and Women's Hospital
Boston Massachusetts, 02215, United States
Dana-Farber Cancer Institute
Boston Massachusetts, 02215, United States
Faulkner Hospital
Boston Massachusetts, 02215, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

9

Study ID:

NCT01568346

Recruitment Status:

Terminated

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.